Leerink Partnrs Predicts Stronger Earnings for Doximity

Doximity, Inc. (NASDAQ:DOCS) – Equities research analysts at Leerink Partnrs upped their FY2027 EPS estimates for Doximity in a research note issued on Monday, March 3rd. Leerink Partnrs analyst M. Cherny now anticipates that the company will earn $1.33 per share for the year, up from their prior forecast of $1.31. Leerink Partnrs has a “Strong-Buy” rating on the stock. The consensus estimate for Doximity’s current full-year earnings is $0.99 per share. Leerink Partnrs also issued estimates for Doximity’s FY2028 earnings at $1.47 EPS.

Several other analysts also recently weighed in on DOCS. Canaccord Genuity Group downgraded shares of Doximity from a “buy” rating to a “hold” rating and lifted their target price for the company from $40.00 to $60.00 in a report on Wednesday, November 13th. Wells Fargo & Company reiterated an “equal weight” rating on shares of Doximity in a report on Friday, February 7th. Stephens began coverage on Doximity in a report on Friday, December 20th. They set an “equal weight” rating and a $55.00 target price for the company. Bank of America boosted their price target on shares of Doximity from $54.00 to $57.00 and gave the stock a “neutral” rating in a research note on Monday, January 6th. Finally, JPMorgan Chase & Co. raised their price objective on shares of Doximity from $30.00 to $48.00 and gave the company a “neutral” rating in a research note on Thursday, November 21st. Eleven analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, Doximity has a consensus rating of “Moderate Buy” and a consensus price target of $64.22.

Doximity Stock Performance

Doximity stock opened at $68.22 on Tuesday. The company’s 50 day simple moving average is $62.11 and its 200-day simple moving average is $50.95. Doximity has a 1 year low of $22.96 and a 1 year high of $85.21. The company has a market capitalization of $12.74 billion, a price-to-earnings ratio of 68.22, a price-to-earnings-growth ratio of 4.10 and a beta of 1.39.

Insider Buying and Selling at Doximity

In other news, Director Timothy S. Cabral sold 20,000 shares of the company’s stock in a transaction on Monday, February 3rd. The shares were sold at an average price of $57.62, for a total value of $1,152,400.00. Following the completion of the transaction, the director now owns 6,360 shares in the company, valued at approximately $366,463.20. This represents a 75.87 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. 37.40% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Doximity

Institutional investors and hedge funds have recently bought and sold shares of the stock. QSV Equity Investors LLC increased its position in shares of Doximity by 0.3% during the fourth quarter. QSV Equity Investors LLC now owns 60,763 shares of the company’s stock worth $3,244,000 after purchasing an additional 186 shares in the last quarter. Handelsbanken Fonder AB grew its stake in Doximity by 0.7% during the 4th quarter. Handelsbanken Fonder AB now owns 29,700 shares of the company’s stock worth $1,586,000 after buying an additional 200 shares during the last quarter. UMB Bank n.a. increased its position in Doximity by 69.1% during the fourth quarter. UMB Bank n.a. now owns 575 shares of the company’s stock worth $31,000 after buying an additional 235 shares during the period. Fielder Capital Group LLC lifted its stake in Doximity by 4.5% in the fourth quarter. Fielder Capital Group LLC now owns 5,488 shares of the company’s stock valued at $293,000 after buying an additional 235 shares during the last quarter. Finally, Larson Financial Group LLC boosted its holdings in shares of Doximity by 49.4% in the fourth quarter. Larson Financial Group LLC now owns 756 shares of the company’s stock valued at $40,000 after acquiring an additional 250 shares during the period. 87.19% of the stock is owned by hedge funds and other institutional investors.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.